Non Small Cell Lung Cancer (Squamous or Non Squamous) Clinical Trials in New York, New York

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.